Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Lee Scheinbart

General Oncology · Burrell College of Osteopathic Medicine

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    EPDr. Emanuela Palmerini

    Dr. Emanuela Palmerini

    Medical Oncology · Sarcoma
    University of Miami
    emanuela
    Miami, FL, USA

    Research

    What is debridement, antibiotics, and implant retention in orthopaedic oncology? : a global cross-sectional survey of surgeons' practices and opinions.

    2025

    Via Bone & Joint Open

    Research

    Radiomics in Soft Tissue Sarcoma: Toward Precision Imaging in Oncology.

    2025

    Via Cancers

    Research

    A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

    2025

    Via The Bone & Joint Journal

    Research

    Precision oncology in soft tissue sarcomas: from pathology to clinical implementation.

    2024

    Via The Lancet Oncology

    Research

    Neoadjuvant chemotherapy in non-metastatic high-risk soft-tissue sarcomas: does it improve outcomes?

    2024

    Via European Journal of Cancer

    Research

    Pembrolizumab in combination with trabectedin for treatment of unresectable or metastatic liposarcoma (PEMBRYO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

    2024

    Via The Lancet

    Research

    Adjuvant therapy in resectable soft-tissue and bone sarcomas: ESMO clinical practice guidelines.

    2024

    Via Annals of Oncology

    Research

    Systemic therapy in dermatofibrosarcoma protuberans: results from the Italian Rare Cancers Network database.

    2024

    Via Cancer Treatment Reviews

    Research

    Doxorubicin, ifosfamide and high-dose methotrexate (APO regimen) compared with epirubicin, cisplatin and high-dose methotrexate (EMA regimen) in patients with high-grade osteosarcoma: results of the EuroOsteosarcoma collaboration.

    2024

    Via Annals of Oncology

    Research

    Management of bone sarcomas: standard of care and emerging approaches.

    2024

    Via Nature Reviews Clinical Oncology

    Research

    Systemic therapy outcomes and patterns of care in angiosarcoma and other soft-tissue sarcomas: results of a retrospective multicentre study.

    2024

    Via ESMO Open

    Research

    Eribulin in combination with standard chemotherapy in patients with angiosarcoma: the ANGIOTAX trial.

    2024

    Via The Lancet Oncology

    Research

    Genomic correlates of immunotherapy response in soft-tissue sarcoma.

    2024

    Via Nature Medicine

    Research

    Combined modality therapy in localized extraosseous Ewing sarcoma: outcomes of the Euro-Ewing 99 trial.

    2024

    Via Journal of Clinical Oncology

    Research

    Neurofibromatosis type 1-associated malignancies: clinical characteristics and management.

    2023

    Via The Oncologist